Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02469662 · ClinicalTrials.gov registry record · NA
Clinical Outcomes Study of the Nexel Total Elbow
A NA study of Post Traumatic Arthritis and Degenerative Arthritis, sponsored by Zimmer Biomet.
- Recruiting
- Registry status
- NA
- Development phase
- 134
- Enrollment target
- 11
- Study locations
NCT02469662: Recruiting NA study of Post Traumatic Arthritis and Degenerative Arthritis, sponsored by Zimmer Biomet.
NCT02469662 is a NA study of Post Traumatic Arthritis and Degenerative Arthritis that is actively recruiting participants, run by Zimmer Biomet. The registered enrollment target is 134 participants, roughly in line with the 144-participant average among 13 other Post Traumatic Arthritis trials with a reported enrollment target. The trial reports 11 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02469662, a NA study of Post Traumatic Arthritis and Degenerative Arthritis, is actively recruiting participants, sponsored by Zimmer Biomet.
- RECRUITING
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
- 11
- Study locations
Study Summary
The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.
Primary Outcome
Based on removal or intended removal of the device and determined using the Kaplan-Meier method
Conditions Studied
Interventions
- DEVICE Nexel Total Elbow
Study Locations (11)
Other
- Coxa Hospital - Tampere
- Hôpital Purpan (Centre Hospitalier Universitaire Toulouse) - Toulouse
- Arcus Sportklinik - Pforzheim
- AO Mauriziano - Torino
- Amphia Ziekenhuis Breda - Breda
- Wrightington - Wigan
Colorado
- Panorama Orthopedics and Spine Center - Golden
North Carolina
- OrthoCarolina Research Institute - Charlotte
Pennsylvania
- Rothman Institute - Philadelphia
Tennessee
- Campbell Clinic - Germantown
New South Wales
- Sydney Shoulder & Elbow, NSW - Sydney
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2015-06 |
| Est. Completion | 2036-12 |
| Phase | NA |
What NCT02469662 shows while recruiting
NCT02469662 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 144-participant average among 13 other Post Traumatic Arthritis trials with a reported enrollment target.
The record links to 10 conditions, with Post Traumatic Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Nexel Total Elbow is the first listed.
NCT02469662 lists 11 locations in 6 states (Other, Colorado, North Carolina).
Frequently Asked Questions
What is clinical trial NCT02469662 about?
NCT02469662 is a clinical study titled "Clinical Outcomes Study of the Nexel Total Elbow". The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.
What is the current status of trial NCT02469662?
This trial is currently recruiting. It is a NA study. The enrollment target is 134 participants. The study started on 2015-06. Estimated completion is 2036-12.
What conditions does trial NCT02469662 study?
This clinical trial studies the following conditions: Post Traumatic Arthritis, Degenerative Arthritis, Elbow Joint Destruction, Post-traumatic Lesions, Ankylosed Joints.
What interventions are being tested in trial NCT02469662?
The interventions under investigation include: Nexel Total Elbow (DEVICE).
Who is sponsoring clinical trial NCT02469662?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02469662 being conducted?
This trial has 11 study locations across Colorado, North Carolina, Pennsylvania, Tennessee, New South Wales. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02469662's enrollment target sits among peer trials
134 7th of 13 higher than 7 of 13 other Post Traumatic Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Zimmer Trabecular Metal Total Ankle PMCF
ACTIVE NOT RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
ACTIVE NOT RECRUITING · NA
-
Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty
ACTIVE NOT RECRUITING · NA
-
2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use
COMPLETED · NA
-
Robotic Arm Assisted Total Knee Arthroplasty
COMPLETED · NA
-
Clinical Investigation of the LCS® Complete Posterior Stabilized Mobile-bearing Total Knee System
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
- NCT05764720 · 134 participants · NA
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia